Evidence map›Paper›PMID 42716934›Full record

ArticleNature communications2026

Neutrophil extracellular traps promote liver metastasis by impairing NK cell-dependent tumor surveillance via CCDC25.

Yetong Zhang, Jiayi Zeng, Heliang Li, Yujiang Liu, Jianghua Lin, Zhijie Zeng, Ruiyue Wu, Xinyan Liang, Xiaoming Zhong, Linxi Xu and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yetong Zhang *Breast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Jiayi Zeng *Breast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Heliang Li *Breast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Yujiang Liu *Breast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.ORCID http://orcid.org/0009-0004-3314-8543
Jianghua Lin *Breast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Zhijie ZengBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Ruiyue WuThe First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, P. R. China.
Xinyan LiangBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Xiaoming ZhongBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.ORCID http://orcid.org/0009-0003-0409-6900
Linxi XuBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Xu LiuBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Zhou LiuDepartment of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
Jieyu FangBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Sicong DuBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Jiao WangSchool of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Erwei SongBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China. songew@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-5400-9049
Linbin YangBreast Tumor Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China. yanglb8@mail.sysu.edu.cn.ORCID http://orcid.org/0009-0000-6326-5231

Funding

China Postdoctoral Science Foundation 2024M763778National Natural Science Foundation of China (National Science Foundation of China) 82222055, 32270971 and 82573214National Natural Science Foundation of China (National Science Foundation of China) 82488101
6 · The paper itself

Abstract

Tumor metastasis requires constant crosstalk between primary tumor cells and immune cells in distant organs, yet how this interaction shapes the evolving immune landscape of metastatic sites remains unclear. Here, using longitudinal single-cell RNA sequencing in a 4T1 orthotopic breast cancer model, we observe a progressive infiltration of neutrophils, robust NETosis and an immunosuppressive niche during metastatic progression in the liver. Through multiple in vivo models, we determine that macrophage-dependent neutrophil extracellular trap (NET) formation serves as a potent driver of liver metastasis. Mechanistically, extracellular NET-derived DNA is sensed by the transmembrane protein coiled-coil domain containing 25 (CCDC25) on natural killer (NK) cells, and the NET-CCDC25 interaction impairs NK cell surveillance by downregulating multiple activating receptors, including NKG2D, NKp46, NKp44, via the CCDC25-ILK-STAT3 axis. In clinical metastatic liver samples, a higher level of NET expression is associated with NK cell dysfunction. Overall, our findings identify CCDC25 as a potential "innate immune checkpoint" on NK cells, revealing a promising therapeutic strategy to reactivate NK cell function to inhibit liver metastasis.

Indexed as

Extracellular TrapsKiller Cells, NaturalLiver NeoplasmsMembrane ProteinsNeutrophilsAnimalsBreast NeoplasmsCell Line, TumorFemaleHumansImmunologic SurveillanceMiceMice, Inbred BALB CMembrane Proteins

Identifiers

PMID42716934
PMCPMC13558603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.